BioCentury
ARTICLE | Clinical News

PG-TXL polyglutamate-linked paclitaxel derivative regulatory update

November 15, 1999 8:00 AM UTC

PG-TXL Co. LP (Houston, Texas) received U.S. Patent No. 5,977,163 covering water-soluble compositions of multiple chemotherapeutics, including Bristol-Myers Squibb Co.'s Taxol paclitaxel. CTIC is th...